Work

Complications of hyperglycemia in phase 1 trials targeting the PI3K-akt-mTOR (PAM) pathway.

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.15_suppl.2612

Authors: Elena Geuna, Desamparados Roda, Saeed Rafii, Begona Jimenez, Marta Capelan, Karim Rihawi, Timothy Anthony Yap, Stanley B. Kaye, Johann Sebastian De Bono, L Rhoda Molife, Udai Banerji

Institutions: Royal Marsden NHS Foundation Trust, Institute of Cancer Research, Royal Marsden Hospital

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2598771270

Cites:

Cited by:

Related to: 10